A Double-blind Study to Assess 2 Doses of an Investigational Product for 16 Weeks in Participants With Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus
Clinical trial NCT03969719 · COMPLETED
Trial details
- NCT number
- NCT03969719
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-18
- Primary completion
- 2021-03-02
- Enrollment
- 164
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.